Log In
BCIQ
Print this Print this
 

SR-Octreotide (PT201)

  Manage Alerts
Collapse Summary General Information
Company Peptron Inc.
Description1-month injectable formulation of octreotide, a somatostatin analog
Molecular Target Somatostatin receptor
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPilot
Standard IndicationAcromegaly
Indication DetailsTreat acromegaly
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today